NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...
Microbes that reside peaceably in the nasal passageways and on the skin can be harnessed for taking drugs to target cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback